NLP
LRMR icon

Next Level Private’s Larimar Therapeutics LRMR Stock Holding History

Next Level Private’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Hold
41,700
– – 0.02% 173
2026
Q1 		$188K Hold
41,700
– – 0.04% 174
2025
Q4 		$159K Hold
41,700
– – 0.04% 160
2025
Q3 		$201K Buy
41,700
+21,700
+109% +$81.4K 0.06% 154
2025
Q2 		$57.8K Buy
+20,000
New +$46.3K 0.02% 149

Other funds holding LRMR

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Next Level Private's LRMR Position: Q2 2026 in Review

Next Level Private held its Larimar Therapeutics (LRMR) position steady in Q2 2026 at 41,700 shares worth $127K. The position accounts for 0.02% of the portfolio, ranked #173.

Next Level Private first reported a position in LRMR in Q2 2025 and has held it in 5 quarters since. The position peaked at $201K in Q3 2025. 29 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Next Level Private held 41,700 shares of Larimar Therapeutics worth $127K as of Q2 2026.
  • Next Level Private left its Larimar Therapeutics share count unchanged in Q2 2026.
  • Larimar Therapeutics made up 0.02% of Next Level Private's portfolio in Q2 2026, its #173 holding.
  • Next Level Private first reported a position in Larimar Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Next Level Private's Larimar Therapeutics position peaked at $201K in Q3 2025.
  • 29 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Next Level Private's 13F filing for Q2 2026, filed 9 Jul 2026.